Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Amy Tu’s office at (888) 731-8994 to ask if they take your plan before you enroll.
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 31 Part D prescriptions in 2023. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
Part D prescribing by year
2023
31
12
0% (0)
61%
$2,573
2022
355
74
0% (0)
28%
$38,061
2021
479
86
0% (0)
22%
$49,688
2020
383
82
0% (0)
27%
$41,330
2019
433
104
0% (0)
30%
$50,054
2018
526
137
0% (0)
24%
$66,105
2017
332
105
0% (0)
31%
$30,435
2016
141
58
0% (0)
48%
$19,193
2015
418
116
0% (0)
59%
$60,067
2014
195
68
0% (0)
53%
$20,967
2013
14
11
0% (0)
—None
$824
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
Part D drugs prescribed in 2023
Estradiol (Twice Weekly)
18
$1,383
$77
2022: 10 drugs
Part D drugs prescribed in 2022
Estradiol (Twice Weekly)
63
$7,666
$122
Estradiol
29
$4,124
$142
Menostar
13
$3,976
$306
Yuvafem
18
$3,941
$219
Dotti
20
$1,841
$92
Progesterone
61
$1,585
$26
Bupropion Xl
20
$798
$40
Rosuvastatin
14
$674
$48
Gabapentin
15
$245
$16
Amlodipine Besylate
19
$65
$3
2021: 13 drugs
Part D drugs prescribed in 2021
Estradiol (Twice Weekly)
72
$7,753
$108
Estradiol
51
$6,949
$136
Menostar
11
$4,797
$436
Progesterone
92
$3,974
$43
Yuvafem
16
$3,602
$225
Dotti
43
$2,974
$69
Vivelle-Dot
11
$2,665
$242
Rosuvastatin
12
$892
$74
Oxybutynin Chloride Er
15
$679
$45
Bupropion Xl
16
$574
$36
Venlafaxine Hcl Er
11
$520
$47
Gabapentin
26
$297
$11
Paroxetine
11
$188
$17
2020: 11 drugs
Part D drugs prescribed in 2020
Estradiol (Twice Weekly)
53
$6,546
$124
Yuvafem
29
$4,974
$172
Menostar
18
$4,543
$252
Dotti
32
$3,717
$116
Estradiol
20
$3,585
$179
Divigel
12
$2,293
$191
Vivelle-Dot
15
$2,261
$151
Progesterone
43
$1,578
$37
Venlafaxine Hcl Er
29
$426
$15
Bupropion Xl
13
$381
$29
Gabapentin
24
$183
$8
2019: 13 drugs
Part D drugs prescribed in 2019
Repatha Sureclick
11
$10,802
$982
Estradiol
82
$7,587
$93
Vivelle-Dot
21
$4,367
$208
Yuvafem
20
$3,394
$170
Menostar
13
$3,113
$239
Rosuvastatin
21
$2,142
$102
Divigel
15
$2,008
$134
Bupropion Xl
17
$1,297
$76
Progesterone
33
$1,250
$38
Gabapentin
25
$160
$6
Paroxetine
14
$118
$8
Simvastatin
16
$98
$6
Amlodipine Besylate
15
$57
$4
2018: 16 drugs
Part D drugs prescribed in 2018
Praluent
12
$13,658
$1,138
Xarelto
17
$12,929
$761
Ranexa
17
$11,235
$661
Estradiol
36
$3,820
$106
Rosuvastatin
33
$1,893
$57
Valsartan
23
$752
$33
Progesterone
15
$642
$43
Atorvastatin
26
$610
$23
Ramipril
30
$410
$14
Chlorthalidone
12
$407
$34
Carvedilol
31
$403
$13
Amlodipine Besylate
48
$364
$8
Losartan
13
$121
$9
Simvastatin
22
$95
$4
Paroxetine
18
$91
$5
Gabapentin
12
$68
$6
2017: 8 drugs
Part D drugs prescribed in 2017
Estradiol
44
$4,292
$98
Progesterone
12
$649
$54
Metoprolol
19
$346
$18
Atorvastatin
13
$248
$19
Ramipril
17
$191
$11
Amlodipine Besylate
20
$135
$7
Carvedilol
14
$108
$8
Gabapentin
12
$96
$8
2016: 3 drugs
Part D drugs prescribed in 2016
Vagifem
22
$6,193
$282
Estradiol
23
$1,613
$70
Progesterone
20
$1,047
$52
2015: 9 drugs
Part D drugs prescribed in 2015
Vagifem
95
$20,092
$211
Estring
26
$7,021
$270
Premarin
39
$6,506
$167
Estrace
28
$6,270
$224
Progesterone
61
$3,957
$65
Estradiol
35
$2,442
$70
Vivelle-Dot
17
$2,359
$139
Provera
11
$784
$71
Valacyclovir
15
$289
$19
2014: 6 drugs
Part D drugs prescribed in 2014
Vagifem
30
$3,138
$105
Vivelle-Dot
35
$3,029
$87
Estrace
13
$2,767
$213
Progesterone
26
$2,314
$89
Premarin
16
$2,122
$133
Estradiol
16
$434
$27
Money from drug and device companies
$116 in 2023
Industry payments by year
2023
5
6
—None
$116
2022
1
1
—None
$25
2021
1
1
—None
$24
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.